Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry.
Oblitas CM, Demelo-Rodríguez P, Barrera-López L, Galeano-Valle F, Rubio-Rivas M, Luque Del Pino J, Giner Galvañ V, Paredes-Ruíz D, Fernández-Madera Martínez R, Gericó Aseguinolaza M, Gómez-Huelgas R, Fernández FA, Torres Peña JD, Martín González JI, Méndez-Bailón M, Monge Monge D, Freire Castro SJ, Pastor Valverde C, Rodilla-Sala E, Guzmán García M, Rivas-Carmenado M, Gallo CM, Perea Ribis MA, Casas-Rojo JM, Millán Núñez-Cortés J; SEMICOVID-19 Network.
Oblitas CM, et al.
Sci Rep. 2025 Mar 5;15(1):7722. doi: 10.1038/s41598-025-90278-8.
Sci Rep. 2025.
PMID: 40044746
Free PMC article.